skip to primary navigationskip to content
 

04.08.20 Steve Jackson wins Royal Society Mullard Award for research contributing to national prosperity

last modified Aug 04, 2020 11:41 AM
The Royal Society Mullard Award 2020 is awarded to Professor Steve Jackson for his research that led to the discovery of olaparib, which has reached blockbuster status for the treatment of ovarian and breast cancers.
04.08.20 Steve Jackson wins Royal Society Mullard Award for research contributing to national prosperity

Prof Stephen Jackson FMedSci FRS

Prof Steve Jackson awarded the Royal Society Mullard Award 2020

 

...for his pioneering research on DNA repair mechanisms and synthetic lethality that led to the discovery of olaparib, which has reached blockbuster status for the treatment of ovarian and breast cancers.

Prof Jackson said "It is a great honour to receive the Royal Society Mullard Award in recognition of how my research has helped pave the way for new cancer therapies. This achievement has, of course, only been possible because of the dedication and efforts of a great many people who have worked to translate concepts and findings arising from fundamental discoveries made in my academic group through drug discovery and drug development."

Professor Jackson's achievement will be celebrated at the Royal Society's Anniversary Day on 30th November 2020. 

 

The award

The Royal Society Mullard Award was provided by a gift to the Society by the Board of Directors of Mullard Ltd. The Mullard Award is awarded to those who have an outstanding academic record in any area of natural science, engineering or technology and whose work is currently making or has the prospect to make a contribution to national prosperity in the United Kingdom. The award includes a silver gilt medal, a travel grant of £1,500 and a gift of £2,000.

"What differentiates the Royal Society Mullard Award from most other scientific awards," says Jackson, "is that it specifically recognises efforts that have or may enhance national prosperity. In my case, it recognises how my fundamental scientific research led me to establish successful biotechnology companies, and how one of these, KuDOS Pharmaceuticals, produced a blockbuster medicine now co-marketed by a UK-based pharmaceutical company... and also nurtured further investment in DNA repair programmes in this company and others, many of which are UK based. I hope that this recognition will help myself and others spearhead further prosperity-enhancing activities."

+++++++++

Watch Steve Jackson describe the principle of synthetic lethality and how olaparib works to defeat cancer in this YouTube video.

 

Institute reopening

The Gurdon Institute reopened on Monday 15th June. Many staff will continue to work from home, and all staff may be contacted by email.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018

 

Share this